Efgartigimod improves triple-negative myasthenia gravis

Neurol Sci. 2024 Mar;45(3):1307-1309. doi: 10.1007/s10072-023-07122-y. Epub 2023 Oct 24.

Rita Frangiamore¹, Elena Rinaldi¹, Fiammetta Vanoli^{1

2}, Francesca Andreetta¹, Renato Mantegazza¹, Carlo Antozzi^{3

4}

¹ Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy.
² Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
³ Neuroimmunology and Muscle Pathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy. carlo.antozzi@istituto-besta.it.
⁴ Immunotherapy and Apheresis Departmental Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Giovanni Celoria 11, 20133, Milan, Italy. carlo.antozzi@istituto-besta.it.

No abstract available

Publication types